Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Boston Scientific Founder John Abele Joins Nanobiosym Global Advisory Board

John Abele, Founding Chairman, Boston Scientific (Photo: Business Wire)
John Abele, Founding Chairman, Boston Scientific (Photo: Business Wire)

Abstract:
Abele to advise leading nanotech firm as it brings game-changing technologies to enable new healthcare paradigms

Boston Scientific Founder John Abele Joins Nanobiosym Global Advisory Board

Boston, MA | Posted on September 24th, 2009

Nanobiosym® today announced that John Abele, Cofounder and former Co-Chairman of the multibillion-dollar global medical device company, Boston Scientific, has joined the Nanobiosym Global Advisory Board.

Over the past 30 years, Mr. Abele led the adoption of game-changing technologies to enable new paradigms in healthcare such as angioplasty, therapeutic endoscopy, and the use of catheters to treat vascular disease. A pioneer in the development of "minimally invasive medicine," Mr. Abele is a globally recognized thought leader on technological, social and economic issues affecting healthcare.

"I am honored to welcome Mr. Abele to our Global Advisory Board," said Nanobiosym® Chairman and CEO, Dr. Anita Goel, MD, PhD - a Harvard and MIT-trained physicist and physician. "I am inspired by his legacy which provides us with a practical roadmap for bringing disruptive technologies to market and creating entirely new ecosystems to drive cultural change in our healthcare system."

Nanobiosym has developed Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism. Dr. Goel's vision is to give patients worldwide real-time access to their own diagnostic information through low-cost handheld devices that could detect disease from a single drop of blood or saliva.

"Nanobiosym's technology platform is truly game-changing and has the potential to radically redefine the rules of medical diagnosis." Mr. Abele said. "Dr. Goel's approach to medicine through the lens of physics and nanotechnology could bring about fundamental paradigm shifts in modern medicine, possibly even quantum leaps in how we diagnose and heal diseases. At Boston Scientific we fostered a culture of exploration and discovery and I see that same drive and passion at Nanobiosym. I am delighted to join the Nanobiosym Global Advisory Board, and I look forward to working very closely with Dr. Goel and her team." Mr. Abele joins Ratan Tata, Alfred Ford, and Ambassador John Palmer on the Nanobiosym Global Advisory Board.

Named by MIT's Technology Review as one of the world's top science and technology innovators working at the forefront of physics, biomedicine, and nanotechnology, Dr. Goel has a passion for innovating holistically across conventional disciplines. "We are deeply committed to bringing our scientific innovations to address some of the greatest humanitarian needs and challenges facing our planet," said Dr. Goel.

"Dr. Goel's vision for science is holistically shaped by the needs of the greater good," said Mr. Abele. "It is one thing to give the world great science and technology. But it is even greater to have the vision to use this science and technology to create a global impact that transcends boundaries between scientific disciplines, between academia and industries, and even between various geopolitical and socioeconomic arenas. Dr. Goel, a rare blend of scientist, entrepreneur and visionary, is paving the path to a better global future."

####

For more information, please click here

Contacts:
Nanobiosym
Jennifer Wilson, 508-282-7156

Copyright © Business Wire 2009

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Nanomedicine

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Announcements

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Appointments/Promotions/New hires/Resignations/Deaths

Ocean Optics Grows Sales Organization with Executive Appointments: Henry Langston promoted, Christine Stannard joins spectral sensing product developer December 23rd, 2017

Emmanuel Sabonnadiere is Leti’s New CEO November 28th, 2017

Nanometrics Board of Directors Names Pierre-Yves Lesaicherre President and CEO November 14th, 2017

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project